Dr. Kristopher Attwood Kristopher Attwood, PhD

Kristopher Attwood

PhD

Special Interests:

Classification Problems Decision Theory Operations Research Statistics Education

About Kristopher Attwood

Biography:

Dr. Attwood earned his PhD and MA in Biostatistics from the SUNY University at Buffalo (UB). He also earned a BS degree in Applied Mathematics from the University at Rhode Island, as well as a MS degree in Industrial & Systems Engineering from UB.

Dr. Attwood joined the Department of Biostatistics and Bioinformatics at Roswell Park Comprehensive Cancer Center (Roswell Park) as a Senior Biostatistician in 2011. He was later presented with an Assistant Professor of Biostatistics in 2012 at Roswell Park. In this capacity he has designed, reviewed and analyzed clinical, pre-clinical and translational studies for a variety of disease settings and outcomes. He regularly works with the Departments of Urology and Surgical Oncology, and is a current member of the Scientific Review Committee. In addition, Dr. Attwood has been teaching undergraduate and graduate level applied statistics courses at Daemen College since 2008.

Positions

Roswell Park Comprehensive Cancer Center
  • Assistant Professor of Oncology
  • Co-Director, Biostatistics and Statistical Genomics Shared Resource
  • Department of Biostatistics and Bioinformatics
State University of New York at Buffalo
  • Research Assistant Professor

Background

Education and Training:

  • PhD - State University of New York at Buffalo, Buffalo, NY
  • MA - State University of New York at Buffalo, Buffalo, NY
  • MS - State University of New York at Buffalo, Buffalo, NY
  • BS - University of Rhode Island, Kingston RI

Research

Research Overview:

Dr. Attwood's collaborative research is supported by several NIH and DOD grants examining treatment options, biomarker indentification/development, and racial disparities in the prostate cancer setting.

He is also developing statistical methodologies for identifying biomarker based decision rules for patient classification (binary and multi-level), treatment, and outcomes (fixed and time dependent).


Publications

Full Publications list on PubMed
  • Attwood K, Tian L, Xiong C. Diagnostic thresholds with three ordinal groups. J Biopharm Stat. 2014;24(3):608-33. doi: 10.1080/10543406.2014.888437. PMID: 24707966; PMCID: PMC4307385.
  • Montgomery E, Gao C, de Luca J, Bower J, Attwood K, Ylagan L. Validation of 31 of the most commonly used immunohistochemical antibodies in cytology prepared using the Cellient(®) automated cell block system. Diagn Cytopathol. 2014 Dec;42(12):1024-33. doi: 10.1002/dc.23155. Epub 2014 Mar 27. PMID: 24678031.
  • Koulikov D, Mohler MC, Mehedint DC, Attwood K, Wilding GE, Mohler JL. Low detectable prostate specific antigen after radical prostatectomy—treat or watch? J Urol. 2014 Nov;192(5):1390-6. doi: 10.1016/j.juro.2014.05.088. Epub 2014 May 21. PMID: 24859441; PMCID: PMC4586061.
  • Poch MA, Mehedint D, Green DJ, Payne-Ondracek R, Fontham ET, Bensen JT, Attwood K, Wilding GE, Guru KA, Underwood W, Mohler JL, Heemers HV. The association between calcium channel blocker use and prostate cancer outcome. Prostate. 2013 Jun;73(8):865-72. doi: 10.1002/pros.22632. Epub 2012 Dec 31. PMID: 23280547; PMCID: PMC5826547.
  • Schmidt LJ, Duncan K, Yadav N, Regan KM, Verone AR, Lohse CM, Pop EA, Attwood K, Wilding G, Mohler JL, Sebo TJ, Tindall DJ, Heemers HV. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells. Mol Endocrinol. 2012 May;26(5):716-35. doi: 10.1210/me.2011-1130. Epub 2012 Mar 28. PMID: 22456196; PMCID: PMC3355556.
  • Bailey DW, Nelms BE, Attwood K, Kumaraswamy L, Podgorsak MB. Statistical variability and confidence intervals for planar dose QA pass rates. Med Phys. 2011 Nov;38(11):6053-64. doi: 10.1118/1.3651695. PMID: 22047370.

Request an Appointment

Make an appointment by calling 1-800-ROSWELL (1-800-767-9355)

Make an Appointment